{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:39:49Z","timestamp":1792798789766,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["21\/0006280"],"award-info":[{"award-number":["21\/0006280"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/V015869\/1"],"award-info":[{"award-number":["BB\/V015869\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BBSRC East of Scotland Bioscience Doctoral Training Partnership"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lipodystrophies are a group of disorders featuring reduced adipose tissue mass or function, which often leads to significant metabolic disease, reduced lifespan and impaired quality of life. Individuals with congenital generalised lipodystrophy (CGL) have severely reduced adipose tissue mass. The loss of healthy systemic lipid storage typically causes hepatic steatosis and lipoatrophic diabetes. In addition, adipocyte-secreted hormones including leptin and adiponectin are dramatically reduced. Leptin has critical roles regulating appetite and broader effects on lipid and glucose metabolism. Daily injection with recombinant leptin is currently the only specific, approved treatment for CGL. The consequences of adiponectin loss in these patients are not fully understood. Likewise, the potential therapeutic benefit of adiponectin delivery is unclear. Here we examine the effect of delivering leptin or adiponectin by adeno-associated virus (AAV) as a potential gene therapy treatment for metabolic disease in CGL using a well-characterised murine model of the condition. AAV-mediated leptin delivery significantly improved hepatic steatosis and hyperinsulinemia. However, adiponectin delivery did not lead to any observed beneficial effects. This demonstrates that gene therapy approaches may have the potential to offer long-term delivery of leptin in individuals with lipodystrophy, without the need for continuous supply of perishable therapeutics and painful daily injections.<\/jats:p>","DOI":"10.1038\/s41434-026-00646-w","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:45:25Z","timestamp":1792752325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2380-7117","authenticated-orcid":false,"given":"Nadine","family":"Sommer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6831-4426","authenticated-orcid":false,"given":"Ahlima","family":"Roumane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7665-0878","authenticated-orcid":false,"given":"Mansi","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7731-1419","authenticated-orcid":false,"given":"Lora K.","family":"Heisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-4355","authenticated-orcid":false,"given":"George D.","family":"Mcilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-4939","authenticated-orcid":false,"given":"Justin J.","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"646_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/db19-0447","volume":"69","author":"C Gonzaga-Jauregui","year":"2020","unstructured":"Gonzaga-Jauregui C, Ge W, Staples J, Van Hout C, Yadav A, Colonie R, et al. Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort. Diabetes. 2020;69:249\u201358.","journal-title":"Diabetes"},{"key":"646_CR2","doi-asserted-by":"crossref","unstructured":"Lim K, Haider A, Adams C, Sleigh A, Savage D. Lipodystrophy: a paradigm for understanding the consequences of \u2018overloading\u2019 adipose tissue. Physiol Rev. 2020;101:907-93.","DOI":"10.1152\/physrev.00032.2020"},{"key":"646_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng585","volume":"28","author":"J Magr\u00e9","year":"2001","unstructured":"Magr\u00e9 J, Del\u00e9pine M, Khallouf E, Gedde-Dahl T, Van Maldergem L, Sobel E, et al. Identification of the gene altered in Berardinelli\u2013Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28:365\u201370.","journal-title":"Nat Genet"},{"key":"646_CR4","doi-asserted-by":"publisher","first-page":"e0199052","DOI":"10.1371\/journal.pone.0199052","volume":"13","author":"JG Lima","year":"2018","unstructured":"Lima JG, Nobrega LHC, Lima NN, dos Santos MCF, Silva PHD, Baracho M, et al. Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy. PLoS One. 2018;13:e0199052.","journal-title":"PLoS One"},{"key":"646_CR5","doi-asserted-by":"publisher","unstructured":"Tiwari M, Mcilroy GD. From scarcity to solutions: therapeutic strategies to restore adipose tissue functionality in rare disorders of lipodystrophy. Diab Med. 2023;40. https:\/\/doi.org\/10.1111\/dme.15214","DOI":"10.1111\/dme.15214"},{"key":"646_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI0215001","volume":"109","author":"KF Petersen","year":"2002","unstructured":"Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Investig. 2002;109:1345\u201350.","journal-title":"J Clin Investig"},{"key":"646_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1530\/EJE-09-1027","volume":"162","author":"J Beltrand","year":"2010","unstructured":"Beltrand J, Lahlou N, Le Charpentier T, Sebag G, Leka S, Polak M, et al. Resistance to leptin-replacement therapy in Berardinelli\u2013Seip congenital lipodystrophy: an immunological origin. Eur J Endocrinol. 2010;162:1083\u201391.","journal-title":"Eur J Endocrinol"},{"key":"646_CR8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/db06-0263","volume":"55","author":"PE Scherer","year":"2006","unstructured":"Scherer PE. Adipose tissue. Diabetes. 2006;55:1537\u201345.","journal-title":"Diabetes"},{"key":"646_CR9","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1074\/jbc.M209033200","volume":"278","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob\/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003;278:2461\u20138.","journal-title":"J Biol Chem"},{"key":"646_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Investig. 2003;112:91\u2013100.","journal-title":"J Clin Investig"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1706910","volume":"381","author":"KA High","year":"2019","unstructured":"High KA, Roncarolo MG. Gene Therapy. N England J Med. 2019;381:455\u201364.","journal-title":"N England J Med"},{"key":"646_CR12","doi-asserted-by":"publisher","unstructured":"Au HKE, Isalan M, Mielcarek M. Gene therapy advances: a meta-analysis of AAV usage in clinical settings. Front Med (Lausanne) 2022; 8. https:\/\/doi.org\/10.3389\/fmed.2021.809118.","DOI":"10.3389\/fmed.2021.809118"},{"key":"646_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","volume":"20","author":"DA Kuzmin","year":"2021","unstructured":"Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173\u20134.","journal-title":"Nat Rev Drug Discov"},{"key":"646_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL, Strohl WR. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs. 2017;31:317\u201334.","journal-title":"BioDrugs"},{"key":"646_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/v17020239","volume":"17","author":"L Zwi-Dantsis","year":"2025","unstructured":"Zwi-Dantsis L, Mohamed S, Massaro G, Moeendarbary E. Adeno-associated virus vectors: principles, practices, and prospects in gene therapy. Viruses. 2025;17:239.","journal-title":"Viruses"},{"key":"646_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"J-H Wang","year":"2024","unstructured":"Wang J-H, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024;9:78.","journal-title":"Signal Transduct Target Ther"},{"key":"646_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16:1073\u201380.","journal-title":"Mol Ther"},{"key":"646_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.omtm.2022.09.014","volume":"27","author":"N Sommer","year":"2022","unstructured":"Sommer N, Roumane A, Han W, Delibegovi\u0107 M, Rochford JJ, Mcilroy GD. Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy. Mol Ther Methods Clin Dev. 2022;27:206\u201316.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"646_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/jcm10030441","volume":"10","author":"A Roumane","year":"2021","unstructured":"Roumane A, Mcilroy GD, Balci A, Han W, Delibegovi\u0107 M, Baldassarre M, et al. Bscl2 deficiency does not directly impair the innate immune response in a murine model of generalized lipodystrophy. J Clin Med. 2021;10:441.","journal-title":"J Clin Med"},{"key":"646_CR20","doi-asserted-by":"publisher","unstructured":"Roumane A, Mcilroy GD, Sommer N, Han W, Heisler LK, Rochford JJ. GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy. Front Endocrinol (Lausanne) 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1379228.","DOI":"10.3389\/fendo.2024.1379228"},{"key":"646_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molmet.2018.01.019","volume":"10","author":"GD Mcilroy","year":"2018","unstructured":"Mcilroy GD, Suchacki K, Roelofs AJ, Yang W, Fu Y, Bai B, et al. Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease. Mol Metab. 2018;10:55\u201365.","journal-title":"Mol Metab"},{"key":"646_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41434-024-00471-z","volume":"31","author":"M Tiwari","year":"2024","unstructured":"Tiwari M, Roumane A, Sommer N, Han W, Delibegovi\u0107 M, Rochford JJ, et al. Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy. Gene Ther. 2024;31:445\u201354.","journal-title":"Gene Ther"},{"key":"646_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/43448","volume":"401","author":"I Shimomura","year":"1999","unstructured":"Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73\u20136.","journal-title":"Nature"},{"key":"646_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570\u20138.","journal-title":"N Engl J Med"},{"key":"646_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","volume":"24","author":"GL Robertson","year":"1995","unstructured":"Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am. 1995;24:549\u201372.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"646_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","volume":"53","author":"SA Moran","year":"2004","unstructured":"Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, et al. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism. 2004;53:513\u20139.","journal-title":"Metabolism"},{"key":"646_CR27","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1073\/pnas.95.13.7385","volume":"95","author":"SM Cohen","year":"1998","unstructured":"Cohen SM, Werrmann JG, Tota MR. NMR study of the effects of leptin treatment on kinetics of hepatic intermediary metabolism. Proc Natl Acad Sci. 1998;95:7385\u201390.","journal-title":"Proc Natl Acad Sci"},{"key":"646_CR28","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1172\/JCI95476","volume":"128","author":"RJ Brown","year":"2018","unstructured":"Brown RJ, Valencia A, Startzell M, Cochran E, Walter PJ, Garraffo HM, et al. Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy. J Clin Investig. 2018;128:3504\u201316.","journal-title":"J Clin Investig"},{"key":"646_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ando.2024.05.022","volume":"85","author":"C Vigouroux","year":"2024","unstructured":"Vigouroux C, Mosbah H, Vatier C. Leptin replacement therapy in the management of lipodystrophy syndromes. Ann Endocrinol (Paris). 2024;85:201\u20134.","journal-title":"Ann Endocrinol (Paris)"},{"key":"646_CR30","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cmet.2022.09.020","volume":"34","author":"M Metz","year":"2022","unstructured":"Metz M, Beghini M, Wolf P, Pfleger L, Hackl M, Bastian M, et al. Leptin increases hepatic triglyceride export via a vagal mechanism in humans. Cell Metab. 2022;34:1719\u201331.e5.","journal-title":"Cell Metab"},{"key":"646_CR31","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/hmg\/ddr205","volume":"20","author":"X Cui","year":"2011","unstructured":"Cui X, Wang Y, Tang Y, Liu Y, Zhao L, Deng J, et al. Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet. 2011;20:3022\u201330.","journal-title":"Hum Mol Genet"},{"key":"646_CR32","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.3390\/ijms262412037","volume":"26","author":"S Cobelo-G\u00f3mez","year":"2025","unstructured":"Cobelo-G\u00f3mez S, Garc\u00eda-Formoso L, Fern\u00e1ndez-Pombo A, L\u00e1zare-Iglesias H, D\u00edaz-L\u00f3pez E, Prado-Mora\u00f1a T, et al. Metabolic-associated steatotic liver disease and FGF21 dysregulation in seipin-deficient and BSCL2-associated celia\u2019s encephalopathy murine models. Int J Mol Sci. 2025;26:12037.","journal-title":"Int J Mol Sci"},{"key":"646_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/gt.2014.38","volume":"21","author":"SM O\u2019Neill","year":"2014","unstructured":"O\u2019Neill SM, Hinkle C, Chen S-J, Sandhu A, Hovhannisyan R, Stephan S, et al. Targeting adipose tissue via systemic gene therapy. Gene Ther. 2014;21:653\u201361.","journal-title":"Gene Ther"},{"key":"646_CR34","doi-asserted-by":"publisher","first-page":"14804","DOI":"10.1073\/pnas.93.25.14804","volume":"93","author":"P Muzzin","year":"1996","unstructured":"Muzzin P, Eisensmith RC, Copeland KC, Woo SLC. Correction of obesity and diabetes in genetically obese mice by leptin\u2009gene\u2009therapy. Proc Natl Acad Sci. 1996;93:14804\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"646_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jconrel.2006.05.008","volume":"114","author":"JH Park","year":"2006","unstructured":"Park JH, Lee M, Kim SW. Non-viral adiponectin gene therapy into obese type 2 diabetic mice ameliorates insulin resistance. J Control Release. 2006;114:118\u201325.","journal-title":"J Control Release"},{"key":"646_CR36","doi-asserted-by":"crossref","unstructured":"Kandasamy AD, Sung MM, Boisvenue JJ, Barr AJ, Dyck JRB. Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutr Diabetes. 2012;2:e45.","DOI":"10.1038\/nutd.2012.18"},{"key":"646_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110930","volume":"27","author":"W Huang","year":"2024","unstructured":"Huang W, Bates R, Appana B, Mohammed T, Cao L. Development of an adipose-tropic AAV capsid ablating liver tropism. iScience. 2024;27:110930.","journal-title":"iScience"},{"key":"646_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MOL.0000000000000819","volume":"33","author":"JFC Glatz","year":"2022","unstructured":"Glatz JFC, Nabben M, Luiken JJFP. CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis. Curr Opin Lipidol. 2022;33:103\u201311.","journal-title":"Curr Opin Lipidol"},{"key":"646_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156261","volume":"169","author":"M Beghini","year":"2025","unstructured":"Beghini M, Metz M, Baumgartner C, Wolf P, Bastian M, Hackl M, et al. Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy. Metabolism. 2025;169:156261.","journal-title":"Metabolism"},{"key":"646_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.tem.2024.05.004","volume":"35","author":"Y LI","year":"2024","unstructured":"LI Y, Onodera T, Scherer PE. Adiponectin. Trends Endocrinol Metab. 2024;35:674\u20135.","journal-title":"Trends Endocrinol Metab"},{"key":"646_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol. 2005;23:321\u20138.","journal-title":"Nat Biotechnol"},{"key":"646_CR42","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.3390\/ijms27073196","volume":"27","author":"S Parajuli","year":"2026","unstructured":"Parajuli S, Gallagher T, Flotte TR. Immune toxicities in AAV gene therapy: overview for clinicians. Int J Mol Sci. 2026;27:3196.","journal-title":"Int J Mol Sci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00646-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00646-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00646-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:03:55Z","timestamp":1792796635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00646-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":42,"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00646-w","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GDM and JJR are co-inventors on a patent application for the use of gene therapies designed for the treatment of conditions of lipodystrophy.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were approved by the University of Aberdeen Ethics Review Board. The study was conducted in accordance with the local legislation and institutional requirements and performed under the project license PPL PP4951597 approved by the UK Home Office.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}